Walker Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$449K Buy
15,747
+865
+6% +$23K 0.23% 85
2026
Q2
$358K Buy
14,882
+591
+4% +$15.5K 0.18% 107
2026
Q1
$401K Sell
14,291
-47
-0.3% -$1.25K 0.22% 88
2025
Q4
$357K Buy
14,338
+523
+4% +$13.2K 0.19% 97
2025
Q3
$352K Sell
13,815
-587
-4% -$14.5K 0.2% 97
2025
Q2
$349K Buy
14,402
+1,540
+12% +$35.9K 0.2% 86
2025
Q1
$326K Buy
12,862
+1,264
+11% +$33.1K 0.2% 88
2024
Q4
$308K Buy
11,598
+513
+5% +$13.9K 0.19% 96
2024
Q3
$321K Buy
11,085
+766
+7% +$22.3K 0.2% 95
2024
Q2
$289K Buy
10,319
+340
+3% +$9.36K 0.19% 100
2024
Q1
$277K Buy
9,979
+1,452
+17% +$40.3K 0.18% 107
2023
Q4
$245K Buy
+8,527
New +$258K 0.18% 110
2023
Q3
– Sell
-5,804
Closed -$213K – 96
2023
Q2
$213K Sell
5,804
-31
-0.5% -$1.21K 0.18% 88
2023
Q1
$238K Sell
5,835
-47
-0.8% -$2.03K 0.21% 79
2022
Q4
$301K Buy
5,882
+373
+7% +$17.9K 0.26% 55
2022
Q3
$241K Sell
5,509
-78
-1% -$3.79K 0.22% 64
2022
Q2
$293K Sell
5,587
-157
-3% -$8K 0.26% 56
2022
Q1
$297K Buy
5,744
+13
+0.2% +$675 0.24% 64
2021
Q4
$338K Buy
+5,731
New +$284K 0.3% 47

Other funds holding PFE

Walker Asset Management's PFE Position: Q3 2026 in Review

Walker Asset Management increased its Pfizer (PFE) stake by 5.8% in Q3 2026, buying an estimated $23K and bringing the position to 15,747 shares worth $449K. The position accounts for 0.23% of the portfolio, ranked #85.

Walker Asset Management first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. 561 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Walker Asset Management held 15,747 shares of Pfizer worth $449K as of Q3 2026.
  • Walker Asset Management bought 865 Pfizer shares in Q3 2026, an estimated $23K.
  • Pfizer made up 0.23% of Walker Asset Management's portfolio in Q3 2026, its #85 holding.
  • Walker Asset Management first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • 561 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Walker Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.